Feature Article: The Next Generation of Cell Factories for Viral Vector Production
The true potential of gene therapy – with the incredible promise to treat a vast variety of diseases – will only be realised through enhanced manufacturing practices.
In a recent article published in Genetic Engineering and Biotechnology News, the technologies, approaches and tools needed to standardize viral vector production and ensure the pipeline meets GMP standards are discussed.
In the article, six developers – including Solentim – are showcased, along with their tools and solutions working to streamline production and make viral vector treatments more accessible to patients around the world.
Read the full article here.
Get in touch to find out more about our instruments and reagents, and how we can work with you to optimise your cell line development workflow.
Image Credit: Genetic Engineering and Biotechnology News